Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Hoth Therapeutics Inc (NQ: HOTH ) 0.7260 +0.0255 (+3.64%) Streaming Delayed Price Updated: 3:51 PM EDT, Aug 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Hoth Therapeutics Inc < Previous 1 2 3 4 5 6 7 Next > EXCLUSIVE: The Benzinga Moneymaker Series, 5 Emerging Stocks For Investors To Watch December 29, 2022 Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. The rise of social media and retail traders gave way to countless methods to uncover new information.... Via Benzinga Dow Rises Over 1%; Cal-Maine Foods Shares Plummet December 29, 2022 U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite climbing around 250 points on Thursday. Via Benzinga Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session December 29, 2022 Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001. Via Benzinga FDA Signs Off Hoth Therapeutics' Trial Application For HT-001 For Skin Cancers December 29, 2022 Via Benzinga Hoth Therapeutics Shares Surge On Encouraging Preclinical Data From Alzheimer's Program July 12, 2022 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session December 29, 2022 Via Benzinga Nasdaq Jumps Over 250 Points; Crude Oil Down 1% December 29, 2022 U.S. stocks traded higher midway through trading, with the Dow Jones climbing around 400 points on Thursday. Via Benzinga Dow, Nasdaq Up Triple Digits In Latest Last-Ditch Rally December 29, 2022 Stocks are attempting a last-minute rally before the year comes to a close, as investors react to higher-than-expected jobless claims data. Via Talk Markets Dow Surges 250 Points; Jobless Claims Rise To 225,000 December 29, 2022 U.S. stocks traded higher this morning, with the Dow Jones gaining around 250 points on Thursday. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session December 28, 2022 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session December 21, 2022 Via Benzinga Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session December 20, 2022 Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 296% to $3.71 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who... Via Benzinga Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket December 20, 2022 Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares rose 158% to $2.42 in pre-market trading after the company announced interim results from the ICESECRET study for the treatment of patients with small... Via Benzinga Why Is Hoth Therapeutics (HOTH) Stock Up 24% Today? October 31, 2022 Hoth Therapeutics (HOTH) stock is rising higher on Monday with heavy trading and positive results from a Phase 1 clinical trial of BioLexa. Via InvestorPlace Why Global Payments Shares Are Trading Lower By Around 8%? Here Are 41 Stocks Moving In Monday's Mid-Day Session October 31, 2022 Gainers 1847 Holdings LLC (NASDAQ: EFSH) shares surged 72.7% to $3.25 after the company reported it sees over $60 million in revenue and over $7 million in cash flow from operations in 2023 from its... Via Benzinga Nasdaq Down Over 100 Points; Chicago PMI Drops Further October 31, 2022 U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 100 points on Monday. Via Benzinga Hoth Therapeutics' Atopic Dermatitis Candidate Shows Improvement In Severity, Shares Jump October 31, 2022 Hoth Therapeutics Inc (NASDAQ: HOTH) announced Phase 1b trial data for BioLexa in adult patients with mild-to-moderate atopic dermatitis. Via Benzinga What's Going On With Hoth Therapeutics Stock? October 31, 2022 Hoth Therapeutics Inc (NASDAQ: HOTH) shares are trading higher Monday after the company announced positive BioLexa Phase 1b clinical trial results. Via Benzinga Stocks That Hit 52-Week Lows On Wednesday October 26, 2022 On Wednesday, 53 companies reached new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Friday October 28, 2022 During Friday, 125 stocks hit new 52-week lows. Via Benzinga Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday October 26, 2022 Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company. Via Benzinga Nasdaq Surges Over 200 Points; General Electric Posts Downbeat Earnings October 25, 2022 U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday October 25, 2022 On Tuesday, 120 companies set new 52-week lows. Via Benzinga Why Crown Holdings Shares Are Trading Lower By Around 22%? Here Are 46 Stocks Moving In Tuesday's Mid-Day Session October 25, 2022 Gainers Via Benzinga S&P 500 Rises Over 1%; General Motors Earnings Top Views October 25, 2022 U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1.8% on Tuesday. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday October 25, 2022 We're starting off the day with an overview of the biggest pre-market stock movers on Tuesday and the latest news this morning! Via InvestorPlace Why Qualtrics International Shares Are Trading Sharply Higher; Here Are 23 Stocks Moving Premarket October 25, 2022 Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose 43% to $2.16 in pre-market trading. Astellas Pharma Inc. announced plans to invest a total of $50 million to acquire 15% of Taysha Gene... Via Benzinga Why Hoth Therapeutics Shares Are Falling In Monday's After-Hours Session October 24, 2022 Hoth Therapeutics Inc (NASDAQ: HOTH) shares are trading lower by 11.12% to $0.29 during Monday's after-hours session after the company Via Benzinga Hoth Therapeutics And 3 Other Stocks Under $3 Insiders Are Aggressively Buying September 20, 2022 The Dow Jones jumped by around 197 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around... Via Benzinga The Daily Biotech Pulse: AstraZeneca's COVID-19 Vaccine As Effective As mRNA Shots, Humanigen's Lenzilumab Disappoints In COVID-19 Study, Positive Preclinical Data From Hoth's Alzheimer's Program July 13, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
